Immunotherapy for TB. (Q38025666)

27 August 2017

title

Immunotherapy for TB. (English)

1 reference

27 August 2017

1 reference

T Mark Doherty

1

1 reference

27 August 2017

publication date

1 June 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

4

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

629-647

1 reference

Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection

27 August 2017

cites work

1 reference

Does the onset of tuberculosis in AIDS predict shorter survival? Results of a cohort study in 17 European countries over 13 years. AIDS in Europe Study Group

21 January 2018

1 reference

Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration

21 January 2018

1 reference

Accelerated course of human immunodeficiency virus infection after tuberculosis

21 January 2018

1 reference

New drugs and regimens for treatment of TB.

21 January 2018

1 reference

Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature

21 January 2018

1 reference

Tuberculosis in prisons--forgotten plague

21 January 2018

1 reference

Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial

21 January 2018

1 reference

21 January 2018

1 reference

New tuberculosis drugs on the horizon

21 January 2018

1 reference

A short history of Robert Koch's fight against tuberculosis: those who do not remember the past are condemned to repeat it.

21 January 2018

1 reference

Mycobacterium tuberculosis and the intimate discourse of a chronic infection

21 January 2018

1 reference

Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis

21 January 2018

1 reference

ATPase activity of Mycobacterium tuberculosis SecA1 and SecA2 proteins and its importance for SecA2 function in macrophages

21 January 2018

1 reference

The ESAT-6/CFP-10 secretion system of Mycobacterium marinum modulates phagosome maturation

21 January 2018

1 reference

Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase

21 January 2018

1 reference

Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism

21 January 2018

1 reference

Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47

21 January 2018

1 reference

The regulation of dendritic cell function by calcium-signaling and its inhibition by microbial pathogens

21 January 2018

1 reference

Mycobacterium tuberculosis: here today, and here tomorrow

21 January 2018

1 reference

Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis

21 January 2018

1 reference

Pathogen destruction versus intracellular survival: the role of lipids as phagosomal fate determinants

21 January 2018

1 reference

Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response

21 January 2018

1 reference

A tale of two lipids: Mycobacterium tuberculosis phagosome maturation arrest.

21 January 2018

1 reference

Mycobacterium tuberculosis and the environment within the phagosome

21 January 2018

1 reference

Modulation of transcriptional and inflammatory responses in murine macrophages by the Mycobacterium tuberculosis mammalian cell entry (Mce) 1 complex

21 January 2018

1 reference

Delay of phagosome maturation by a mycobacterial lipid is reversed by nitric oxide

21 January 2018

1 reference

Cord factor trehalose 6,6'-dimycolate (TDM) mediates trafficking events during mycobacterial infection of murine macrophages

21 January 2018

1 reference

Trehalose 6,6'-dimycolate on the surface of Mycobacterium tuberculosis modulates surface marker expression for antigen presentation and costimulation in murine macrophages

21 January 2018

1 reference

Mechanism of inducible nitric oxide synthase exclusion from mycobacterial phagosomes

21 January 2018

1 reference

Nitric oxide: cytokine-regulation of nitric oxide in host resistance to intracellular pathogens

21 January 2018

1 reference

Contribution of alpha/beta and gamma/delta T lymphocytes to immunity against Mycobacterium bovis bacillus Calmette Guérin: studies with T cell receptor-deficient mutant mice

21 January 2018

1 reference

CD1 molecules and CD1-dependent T cells in bacterial infections: a link from innate to acquired immunity?

21 January 2018

1 reference

Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung

21 January 2018

1 reference

IL-17 and Th17 cells in tuberculosis

21 January 2018

1 reference

Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients

21 January 2018

1 reference

Associations between IL12B polymorphisms and tuberculosis in the Hong Kong Chinese population.

21 January 2018

1 reference

Disseminated tuberculosis in interferon gamma gene-disrupted mice

21 January 2018

1 reference

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

21 January 2018

1 reference

Control of human host immunity to mycobacteria.

21 January 2018

1 reference

CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis

21 January 2018

1 reference

Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2

21 January 2018

1 reference

Contribution of CD8+ T cells to control of Mycobacterium tuberculosis infection

21 January 2018

1 reference

Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity

21 January 2018

1 reference

Mycobacterium tuberculosis exerts gene-selective inhibition of transcriptional responses to IFN-gamma without inhibiting STAT1 function

21 January 2018

1 reference

Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway

21 January 2018

1 reference

Clinical correlates of interferon gamma production in patients with tuberculosis

21 January 2018

1 reference

Correlates of protective immune response in tuberculous pleuritis

21 January 2018

1 reference

Intracellular expression of interleukin-4 and interferon-gamma by a Mycobacterium tuberculosis antigen-stimulated CD4+ CD57+ T-cell subpopulation with memory phenotype in tuberculosis patients.

21 January 2018

1 reference

Immunosuppression during active tuberculosis is characterized by decreased interferon- gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor- beta , and interleukin-4 mRNA levels

21 January 2018

1 reference

Increased Interleukin-4 production by CD8 and gammadelta T cells in health-care workers is associated with the subsequent development of active tuberculosis

21 January 2018

1 reference

Ex vivo cytokine mRNA levels correlate with changing clinical status of ethiopian TB patients and their contacts over time

21 January 2018

1 reference

Is interleukin-4delta3 splice variant expression in bovine tuberculosis a marker of protective immunity?

21 January 2018

1 reference

BCG induces protection against Mycobacterium tuberculosis infection in the Wistar rat model

21 January 2018

1 reference

Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis

21 January 2018

1 reference

Longitudinal tracking of cytokines after acute exposure to tuberculosis: association of distinct cytokine patterns with protection and disease development

21 January 2018

1 reference

Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment

21 January 2018

1 reference

Distinct chemokine and cytokine gene expression pattern of murine dendritic cells and macrophages in response to Mycobacterium tuberculosis infection.

21 January 2018

1 reference

Circulating TNF-alpha, TGF-beta, and IL-10 in tuberculosis patients and healthy contacts

21 January 2018

1 reference

Hijacking and exploitation of IL-10 by intracellular pathogens

21 January 2018

1 reference

Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells

21 January 2018

1 reference

DC-SIGN: escape mechanism for pathogens

21 January 2018

1 reference

Tumor necrosis factor is critical to control tuberculosis infection

21 January 2018

1 reference

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report

21 January 2018

1 reference

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

21 January 2018

1 reference

Il-4 influences apoptosis of mycobacterium-reactive lymphocytes in the presence of TNF-alpha.

21 January 2018

1 reference

Tuberculosis (TB) and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and beta2-microglobulin, respectively

21 January 2018

1 reference

Modulation of cell death by M. tuberculosis as a strategy for pathogen survival

21 January 2018

1 reference

Expression of apoptosis-related genes in an Ethiopian cohort study correlates with tuberculosis clinical status

21 January 2018

1 reference

Tumor necrosis factor blockers influence macrophage responses to Mycobacterium tuberculosis

21 January 2018

1 reference

Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages

21 January 2018

1 reference

HIV impairs TNF-alpha mediated macrophage apoptotic response to Mycobacterium tuberculosis

21 January 2018

1 reference

Ineffective cellular immune response associated with T-cell apoptosis in susceptible Mycobacterium bovis BCG-infected mice.

21 January 2018

1 reference

Mycobacterium tuberculosis subverts innate immunity to evade specific effectors

21 January 2018

1 reference

Infection of mice with Mycobacterium avium primes CD8+ lymphocytes for apoptosis upon exposure to macrophages

21 January 2018

1 reference

Apoptosis in mycobacterium tuberculosis infection in mice exhibiting varied immunopathology

21 January 2018

1 reference

Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence

21 January 2018

1 reference

Tuberculosis: unsealing the apoptotic envelope

21 January 2018

1 reference

Virulent clinical isolates of Mycobacterium tuberculosis grow rapidly and induce cellular necrosis but minimal apoptosis in murine macrophages.

21 January 2018

1 reference

Immunological control of tuberculosis: role of tumour necrosis factor and more

21 January 2018

1 reference

Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis

21 January 2018

1 reference

The Mycobacterium tuberculosis cell wall component mycolic acid elicits pathogen-associated host innate immune responses

21 January 2018

1 reference

Toll-like receptor pathways in the immune responses to mycobacteria

21 January 2018

1 reference

Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis.

21 January 2018

1 reference

A mutant of Mycobacterium tuberculosis lacking the 19-kDa lipoprotein Rv3763 is highly attenuated in vivo but retains potent vaccinogenic properties

21 January 2018

1 reference

Mycobacterial infection in TLR2 and TLR6 knockout mice.

21 January 2018

1 reference

Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptors.

21 January 2018

1 reference

Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection

21 January 2018

1 reference

Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages

21 January 2018

1 reference

Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms

21 January 2018

1 reference

Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis

21 January 2018

1 reference

Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages

21 January 2018

1 reference

MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis.

21 January 2018

1 reference

Pseudo-rationale design of efficient TB vaccines: lesson from the mycobacterial 27-kDa lipoprotein

21 January 2018

1 reference

The Mycobacterium tuberculosis recombinant 27-kilodalton lipoprotein induces a strong Th1-type immune response deleterious to protection

21 January 2018

1 reference

A comparative study of host response to three Mycobacterium tuberculosis PE_PGRS proteins

21 January 2018

1 reference

Genetic basis of virulence attenuation revealed by comparative genomic analysis of Mycobacterium tuberculosis strain H37Ra versus H37Rv

21 January 2018

1 reference

Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein

21 January 2018

1 reference

The prognosis of latent tuberculosis: can disease be predicted?

21 January 2018

1 reference

Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting

21 January 2018

1 reference

Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis

21 January 2018

1 reference

Tuberculosis: a problem with persistence

21 January 2018

1 reference

Immune protection against tuberculosis--when is immunotherapy preferable to vaccination?

21 January 2018

1 reference

Tuberculin immunotherapy: its history and lessons to be learned

21 January 2018

1 reference

Skin test performed with highly purified Mycobacterium tuberculosis recombinant protein triggers tuberculin shock in infected guinea pigs

21 January 2018

1 reference

Mycobacterium vaccae as adjuvant therapy to anti-tuberculosis chemotherapy in never-treated tuberculosis patients: a meta-analysis

21 January 2018

1 reference

Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine

21 January 2018

1 reference

RUTI: a new chance to shorten the treatment of latent tuberculosis infection

21 January 2018

1 reference

Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis

21 January 2018

1 reference

Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI.

21 January 2018

1 reference

Effectiveness and safety of a treatment regimen based on isoniazid plus vaccination with Mycobacterium tuberculosis cells' fragments: field-study with naturally Mycobacterium caprae-infected goats.

21 January 2018

1 reference

Prophylactic effect of a therapeutic vaccine against TB based on fragments of Mycobacterium tuberculosis

21 January 2018

1 reference

The T cell response to secreted antigens of Mycobacterium tuberculosis

21 January 2018

1 reference

Vaccination against tuberculosis by DNA injection

21 January 2018

1 reference

The potential use of heat-shock proteins to vaccinate against mycobacterial infections

21 January 2018

1 reference

Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice.

21 January 2018

1 reference

Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis

21 January 2018

1 reference

Mycobacterium hsp65 DNA entrapped into TDM-loaded PLGA microspheres induces protection in mice against Leishmania (Leishmania) major infection.

21 January 2018

1 reference

Recent advances in DNA vaccines for autoimmune diseases

21 January 2018

1 reference

Lack of protection in mice and necrotizing bronchointerstitial pneumonia with bronchiolitis in guinea pigs immunized with vaccines directed against the hsp60 molecule of Mycobacterium tuberculosis

21 January 2018

1 reference

The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis

21 January 2018

1 reference

DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation

21 January 2018

1 reference

Novel prophylactic and therapeutic vaccine against tuberculosis

21 January 2018

1 reference

Novel therapeutic vaccine: granulysin and new DNA vaccine against Tuberculosis

21 January 2018

1 reference

Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene

21 January 2018

1 reference

A multistage tuberculosis vaccine that confers efficient protection before and after exposure.

21 January 2018

1 reference

Tuberculosis subunit vaccines: from basic science to clinical testing

21 January 2018

1 reference

Mtb32 is a promising tuberculosis antigen for DNA vaccination in pre- and post-exposure mouse models

21 January 2018

1 reference

Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis

21 January 2018

1 reference

Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis

21 January 2018

1 reference

Post-exposure vaccination against Mycobacterium tuberculosis

21 January 2018

1 reference

The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin

21 January 2018

1 reference

Treatment of multi-drug-resistant tuberculosis in mice with DNA vaccines alone or in combination with chemotherapeutic drugs.

21 January 2018

1 reference

Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy

21 January 2018

1 reference

Reconsidering adjuvant immunotherapy for tuberculosis

21 January 2018

1 reference

Aerosolized interferon gamma for Mycobacterium avium-complex lung disease

21 January 2018

1 reference

Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report

21 January 2018

1 reference

Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol

21 January 2018

1 reference

Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review

21 January 2018

1 reference

Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis

21 January 2018

1 reference

IL-12Rβ1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey

21 January 2018

1 reference

Lethal tuberculosis in a previously healthy adult with IL-12 receptor deficiency

21 January 2018

1 reference

Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.

21 January 2018

1 reference

Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis.

21 January 2018

1 reference

A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis

21 January 2018

1 reference

Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda.

21 January 2018

1 reference

Vitamin D in the treatment of pulmonary tuberculosis

21 January 2018

1 reference

Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis

21 January 2018

1 reference

High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial

21 January 2018

1 reference

Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages

21 January 2018

1 reference

Shedding light on the vitamin D-tuberculosis-HIV connection

21 January 2018

1 reference

Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

Synthetic and natural immunomodulators acting as interferon inducers

21 January 2018

1 reference

Immunostimulatory neem leaf preparation acts as an adjuvant to enhance the efficacy of poorly immunogenic B16 melanoma surface antigen vaccine

21 January 2018

1 reference

Cytokine profiles of HIV patients with pulmonary tuberculosis resulting from adjunct immunotherapy with herbal phytoconcentrates Dzherelo and Anemin.

21 January 2018

1 reference

Effect of oral immunomodulator Dzherelo in TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOTS.

21 January 2018

1 reference

Treatment of cavitary and infiltrating pulmonary tuberculosis with and without the immunomodulator Dzherelo

21 January 2018

1 reference

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

21 January 2018

1 reference

Protective role of γ/δ T cells and α/β T cells in tuberculosis

21 January 2018

1 reference

Dynamics of plasma cytokine levels in patients with advanced HIV infection and active tuberculosis: implications for early recognition of patients with poor response to anti-tuberculosis treatment

21 January 2018

1 reference

Towards a point-of-care test for active tuberculosis: obstacles and opportunities

21 January 2018

1 reference

A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response

21 January 2018

1 reference

Immunotherapy with Mycobacterium vaccae as an adjunct to chemotherapy in the treatment of pulmonary tuberculosis

21 January 2018

1 reference

Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/IMT.12.52

1 reference

release_ui6qksekdnfazf23jce4gwohmm

27 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ui6qksekdnfazf23jce4gwohmm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference